Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1965 1
1968 1
1971 2
1972 8
1973 1
1974 5
1975 6
1976 5
1977 10
1978 9
1979 6
1980 11
1981 4
1982 6
1983 4
1984 7
1985 6
1986 7
1987 4
1988 7
1989 4
1990 6
1991 3
1992 5
1993 1
1994 12
1995 8
1996 13
1997 17
1998 14
1999 9
2000 20
2001 11
2002 21
2003 33
2004 31
2005 45
2006 53
2007 52
2008 46
2009 58
2010 55
2011 53
2012 72
2013 89
2014 77
2015 81
2016 86
2017 66
2018 88
2019 75
2020 76
2021 84
2022 56
2023 43
2024 50
2025 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,478 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW, Kudaba I, Garrido M, Chung HC, Lee J, Castro HR, Mansoor W, Braghiroli MI, Karaseva N, Caglevic C, Villanueva L, Goekkurt E, Satake H, Enzinger P, Alsina M, Benson A, Chao J, Ko AH, Wainberg ZA, Kher U, Shah S, Kang SP, Tabernero J. Shitara K, et al. Among authors: fuchs c. JAMA Oncol. 2020 Oct 1;6(10):1571-1580. doi: 10.1001/jamaoncol.2020.3370. JAMA Oncol. 2020. PMID: 32880601 Free PMC article. Clinical Trial.
Bile acid metabolism and signalling in liver disease.
Fuchs CD, Simbrunner B, Baumgartner M, Campbell C, Reiberger T, Trauner M. Fuchs CD, et al. J Hepatol. 2025 Jan;82(1):134-153. doi: 10.1016/j.jhep.2024.09.032. Epub 2024 Sep 28. J Hepatol. 2025. PMID: 39349254 Free article. Review.
Cancer Diagnoses After Recent Weight Loss.
Wang QL, Babic A, Rosenthal MH, Lee AA, Zhang Y, Zhang X, Song M, Rezende LFM, Lee DH, Biller L, Ng K, Giannakis M, Chan AT, Meyerhardt JA, Fuchs CS, Eliassen AH, Birmann BM, Stampfer MJ, Giovannucci EL, Kraft P, Nowak JA, Yuan C, Wolpin BM. Wang QL, et al. Among authors: fuchs cs. JAMA. 2024 Jan 23;331(4):318-328. doi: 10.1001/jama.2023.25869. JAMA. 2024. PMID: 38261044 Free PMC article.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, Kostic AD, Giannakis M, Bullman S, Milner DA, Baba H, Giovannucci EL, Garraway LA, Freeman GJ, Dranoff G, Garrett WS, Huttenhower C, Meyerson M, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S. Mima K, et al. Among authors: fuchs cs. Gut. 2016 Dec;65(12):1973-1980. doi: 10.1136/gutjnl-2015-310101. Epub 2015 Aug 26. Gut. 2016. PMID: 26311717 Free PMC article.
Response.
Ng K, Chan AT, Fuchs CS. Ng K, et al. Among authors: fuchs cs. J Natl Cancer Inst. 2015 Jun 4;107(8):djv150. doi: 10.1093/jnci/djv150. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 26048995 Free PMC article. No abstract available.
Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice.
Fuchs CD, Radun R, Dixon ED, Mlitz V, Timelthaler G, Halilbasic E, Herac M, Jonker JW, Ronda OAHO, Tardelli M, Haemmerle G, Zimmermann R, Scharnagl H, Stojakovic T, Verkade HJ, Trauner M. Fuchs CD, et al. Hepatology. 2022 Jan;75(1):125-139. doi: 10.1002/hep.32112. Epub 2021 Dec 4. Hepatology. 2022. PMID: 34387896
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, Dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J; REGARD Trial Investigators. Fuchs CS, et al. Lancet. 2014 Jan 4;383(9911):31-39. doi: 10.1016/S0140-6736(13)61719-5. Epub 2013 Oct 3. Lancet. 2014. PMID: 24094768 Clinical Trial.
1,478 results